Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125745101 | 12574510 | 1 | I | 20160718 | 20160720 | 20160720 | EXP | US-GLAXOSMITHKLINE-US2016GSK103359 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160720 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125745101 | 12574510 | 1 | PS | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | 18644 | ||||||||||||
| 125745101 | 12574510 | 2 | SS | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 25 MG, QD | 0 | 25 | MG | QD | |||||||
| 125745101 | 12574510 | 3 | SS | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125745101 | 12574510 | 4 | C | HYZAAR | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | UNK | U | 0 | ||||||||||
| 125745101 | 12574510 | 5 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | U | 0 | |||||||||||
| 125745101 | 12574510 | 6 | C | METOPROLOL. | METOPROLOL | 1 | UNK, BID | U | 0 | BID | |||||||||
| 125745101 | 12574510 | 7 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | 60 MG, QD | U | 0 | 60 | MG | QD | |||||||
| 125745101 | 12574510 | 8 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | U | 0 | |||||||||||
| 125745101 | 12574510 | 9 | C | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125745101 | 12574510 | 10 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | UNK, QD | U | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125745101 | 12574510 | 1 | Product used for unknown indication |
| 125745101 | 12574510 | 2 | Depression |
| 125745101 | 12574510 | 3 | Product used for unknown indication |
| 125745101 | 12574510 | 4 | Blood pressure abnormal |
| 125745101 | 12574510 | 10 | Chronic obstructive pulmonary disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125745101 | 12574510 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125745101 | 12574510 | Adverse drug reaction | |
| 125745101 | 12574510 | Chronic obstructive pulmonary disease | |
| 125745101 | 12574510 | Drug ineffective | |
| 125745101 | 12574510 | Dyspnoea | |
| 125745101 | 12574510 | Hypertension | |
| 125745101 | 12574510 | Insomnia | |
| 125745101 | 12574510 | Restless legs syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125745101 | 12574510 | 2 | 201605 | 0 |